These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 12646940)

  • 1. Deletions on der(9) chromosome in adult Ph-positive acute lymphoblastic leukemia occur with a frequency similar to that observed in chronic myeloid leukemia.
    Specchia G; Albano F; Anelli L; Storlazzi CT; Zagaria A; Mancini M; Cuneo A; Pane F; Foà R; Manolelli F; Liso V; Rocchi M
    Leukemia; 2003 Mar; 17(3):528-31. PubMed ID: 12646940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular cytogenetic characterization of deletions on der(9) in chronic myelocytic leukemia.
    Zagaria A; Anelli L; Albano F; Vicari L; Schiavone EM; Annunziata M; Pane F; Liso V; Rocchi M; Specchia G
    Cancer Genet Cytogenet; 2006 Jun; 167(2):97-102. PubMed ID: 16737907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
    Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
    Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of BCR/ABL gene rearrangements by interphase fluorescence in situ hybridization (FISH) in BCR/ABL+ leukemias: incidence and underlying genetic abnormalities.
    Primo D; Tabernero MD; Rasillo A; Sayagués JM; Espinosa AB; Chillón MC; Garcia-Sanz R; Gutierrez N; Giralt M; Hagemeijer A; San Miguel JF; Orfao A
    Leukemia; 2003 Jun; 17(6):1124-9. PubMed ID: 12764379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The methylation status of the major breakpoint cluster region in human leukemia cells, including Philadelphia chromosome-positive cells, is linked to the lineage of hematopoietic cells.
    Ohyashiki JH; Ohyashiki K; Kawakubo K; Tauchi T; Shimamoto T; Toyama K
    Leukemia; 1993 Jun; 7(6):801-7. PubMed ID: 8501975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pericentric inv(9)(p22q34) of the der(9)t(9;22)(q34;q11.2) is a recurrent secondary anomaly in Ph-positive leukemia.
    Pan J; Xue Y; Qiu H; Chen S; Zhang J; Wu Y; Shen J; Wang Y
    Cancer Genet Cytogenet; 2010 Dec; 203(2):333-40. PubMed ID: 21156255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coexistence of Philadelphia chromosome positive cells with and without der(9) deletion in a patient with chronic myelogenous leukemia.
    Xinh PT; Vu HA; Nghia H; Binh NT; Van Be T; Van Binh T; Tokunaga K; Sato Y
    Cancer Genet Cytogenet; 2006 Jan; 164(2):122-7. PubMed ID: 16434314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Derivative chromosome 9 deletions are a significant feature of childhood Philadelphia chromosome positive acute lymphoblastic leukaemia.
    Robinson HM; Martineau M; Harris RL; Barber KE; Jalali GR; Moorman AV; Strefford JC; Broadfield ZJ; Cheung KL; Harrison CJ
    Leukemia; 2005 Apr; 19(4):564-71. PubMed ID: 15716990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The prognostic significance of derivative chromosome 9 deletions in chronic myeloid leukemia].
    Wu W; Li JY; Shen YF; Cao XS; Qiu HR; Xu W
    Zhonghua Nei Ke Za Zhi; 2007 May; 46(5):386-8. PubMed ID: 17637307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of complex Ph translocations in cases with chronic myelogenous leukemia and one with acute lymphoblastic leukemia.
    Costa D; Carrió A; Madrigal I; Arias A; Valera A; Colomer D; Aguilar JL; Teixido M; Camós M; Cervantes F; Campo E
    Cancer Genet Cytogenet; 2006 Apr; 166(1):89-93. PubMed ID: 16616117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletions adjacent to BCR and ABL1 breakpoints occur in a substantial minority of chronic myeloid leukemia patients with masked Philadelphia rearrangements.
    De Melo VA; Milojkovic D; Marin D; Apperley JF; Nacheva EP; Reid AG
    Cancer Genet Cytogenet; 2008 Apr; 182(2):111-5. PubMed ID: 18406872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The incidence of submicroscopic deletions in reciprocal translocations is similar in acute myeloid leukemia, BCR-ABL positive acute lymphoblastic leukemia, and chronic myeloid leukemia.
    Bacher U; Schnittger S; Kern W; Hiddemann W; Haferlach T; Schoch C
    Haematologica; 2005 Apr; 90(4):558-9. PubMed ID: 15820957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The different signal patterns of two FISH probes in the FISH detection of Ph-positive leukemia and their clinical significance].
    Jiang H; Xue YQ; Pan JL; Zhang J; Dai HP; Wu YF; Wang Y; Shen J; Chen SN
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Apr; 27(2):166-70. PubMed ID: 20376798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion size characterization of der(9) deletions in Philadelphia-positive chronic myeloid leukemia.
    Douet-Guilbert N; Morel F; Quemener S; Maguer A; Le Bris MJ; Morice P; Berthou C; De Braekeleer M
    Cancer Genet Cytogenet; 2006 Oct; 170(2):89-92. PubMed ID: 17011977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic deletions on other chromosomes involved in variant t(9;22) chronic myeloid leukemia cases.
    Albano F; Specchia G; Anelli L; Zagaria A; Storlazzi CT; Buquicchio C; Roberti MG; Liso V; Rocchi M
    Genes Chromosomes Cancer; 2003 Apr; 36(4):353-60. PubMed ID: 12619159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Deletions of derivative chromosome 9 in 138 patients with chronic myeloid leukemia].
    Wang L; Qian SX; Qiu HR; Wang R; Zhang SJ; Miao KR; Fan L; Xu W; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Apr; 17(2):281-4. PubMed ID: 19379551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of any part of the BCR or ABL gene on the derivative chromosome 9 is a poor prognostic marker in chronic myelogenous leukemia.
    Lee YK; Kim YR; Min HC; Oh BR; Kim TY; Kim YS; Cho HI; Kim HC; Lee YS; Lee DS
    Cancer Genet Cytogenet; 2006 Apr; 166(1):65-73. PubMed ID: 16616113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lineage involvement by BCR/ABL in Ph+ lymphoblastic leukemias: chronic myelogenous leukemia presenting in lymphoid blast vs Ph+ acute lymphoblastic leukemia.
    Anastasi J; Feng J; Dickstein JI; Le Beau MM; Rubin CM; Larson RA; Rowley JD; Vardiman JW
    Leukemia; 1996 May; 10(5):795-802. PubMed ID: 8656674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogenic molecular basis for loss of ABL1-BCR transcription: deletions in der(9)t(9;22) and variants of standard t(9;22) in BCR-ABL1-positive chronic myeloid leukemia.
    Loncarevic IF; Römer J; Starke H; Heller A; Bleck C; Ziegler M; Fiedler W; Liehr T; Clement JH; Claussen U
    Genes Chromosomes Cancer; 2002 Jun; 34(2):193-200. PubMed ID: 11979553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study of deletion of derivative chromosome 9 in patients with Ph+ chronic myeloid leukemia].
    Wu W; Xue YQ; Wu YF; Pan JL; Shen J
    Zhonghua Xue Ye Xue Za Zhi; 2006 Mar; 27(3):183-6. PubMed ID: 16792921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.